journal article·2026-02-04

A Universal Framework Nucleic Acid Platform for Kidney-Targeted Delivery of Natural Bioactive Compounds

Xiaofei Sun, Haozhi Lei, Huaibo Zhang, Shan Tao, Ying Zhu, Guangbo Ge, Chunhai Fan, Jiang Li, Tian Tian

Nano Letters· Volume 26· Issue 4
Publisher page

Abstract

Natural bioactive compounds (NBCs) possess broad therapeutic potential but face major translational barriers, including poor bioavailability and nonspecific biodistribution. Here, we develop a generic NBC delivery platform using computational virtual screening and tetrahedral framework nucleic acids (tFNA). By integrating molecular docking with experimental validation, we demonstrate that 17 of 30 NBCs can be efficiently loaded onto tFNA via noncovalent DNA-groove binding, providing a universal strategy for assessing FNA-based NBCs loading. As a demonstration, a costunolide (COS)-FNA complex was constructed for acute kidney injury (AKI) therapy. This complex leverages the unique properties of tFNA to achieve rapid renal accumulation (5 min) and prolonged retention (12 h). In AKI mice, COS-FNA showed greatly improved bioavailability and achieved significant therapeutic effects at only 1/300 of the conventional COS dose. This study offers a new therapeutic approach for AKI and a flexible platform for broad clinical delivery of NBCs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Natural Compounds in Disease Treatment · Chemotherapy-induced organ toxicity mitigation · Cell death mechanisms and regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research

Shanghai University of Traditional Chinese Medicine

Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acids Chemistry and Nanomedicine

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Institute of Materiobiology

College of Sciences Shanghai University

State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, New Cornerstone Science Laboratory, Frontiers Science Center for Transformative Molecules, Zhang Jiang Institute for Advanced Study and National Center for Translational Medicine

Shanghai Jiao Tong University

Funding

National Key Research and Development Program of China · Shanghai University of Traditional Chinese Medicine · National Natural Science Foundation of China

References (52)

Show source-provided references
1. 10.1002/ptr.709910.1002/ptr.7099 ↗
2. 10.1016/j.pharmthera.2024.10873310.1016/j.pharmthera.2024.108733 ↗
3. 10.1093/nar/gkaa106310.1093/nar/gkaa1063 ↗
4. 10.1039/D3SC90185H10.1039/D3SC90185H ↗
5. 10.1016/j.tem.2023.01.00510.1016/j.tem.2023.01.005 ↗
6. 10.1016/j.apsb.2020.12.02010.1016/j.apsb.2020.12.020 ↗
7. 10.1038/s41401-021-00620-910.1038/s41401-021-00620-9 ↗
8. 10.1016/j.phymed.2022.15430610.1016/j.phymed.2022.154306 ↗
9. 10.1016/j.phymed.2024.15590010.1016/j.phymed.2024.155900 ↗
10. 10.1016/j.phymed.2018.09.21010.1016/j.phymed.2018.09.210 ↗
11. 10.1016/j.lfs.2020.11796610.1016/j.lfs.2020.117966 ↗
12. 10.1002/ptr.805910.1002/ptr.8059 ↗
13. 10.1016/j.phymed.2024.15547210.1016/j.phymed.2024.155472 ↗
14. 10.1016/j.phrs.2024.10709910.1016/j.phrs.2024.107099 ↗
15. 10.1016/j.semcancer.2019.08.01410.1016/j.semcancer.2019.08.014 ↗
16. 10.1016/j.phrs.2024.10710010.1016/j.phrs.2024.107100 ↗
17. 10.1021/acsnano.1c0215810.1021/acsnano.1c02158 ↗
18. 10.1002/smtd.20257003910.1002/smtd.202570039 ↗
19. 10.1038/s41596-022-00791-710.1038/s41596-022-00791-7 ↗
20. 10.1016/j.bioactmat.2023.10.02510.1016/j.bioactmat.2023.10.025 ↗
21. 10.1038/s41392-021-00727-910.1038/s41392-021-00727-9 ↗
22. 10.1002/adma.20250571410.1002/adma.202505714 ↗
23. 10.1002/smtd.20240100710.1002/smtd.202401007 ↗
24. 10.1002/anie.20241111810.1002/anie.202411118 ↗
25. 10.1002/smll.20241016210.1002/smll.202410162 ↗
26. 10.1038/s41392-024-01736-010.1038/s41392-024-01736-0 ↗
27. 10.1002/adma.20250972710.1002/adma.202509727 ↗
28. 10.1021/acsnano.4c1642710.1021/acsnano.4c16427 ↗
29. 10.1021/acs.nanolett.1c0104410.1021/acs.nanolett.1c01044 ↗
30. 10.1002/adma.20231019910.1002/adma.202310199 ↗
31. 10.1002/advs.20210594710.1002/advs.202105947 ↗
32. 10.1038/s41551-018-0317-810.1038/s41551-018-0317-8 ↗
33. 10.1016/j.biomaterials.2025.12323710.1016/j.biomaterials.2025.123237 ↗
34. 10.1021/acsnano.3c0210210.1021/acsnano.3c02102 ↗
35. 10.1002/adma.20210782010.1002/adma.202107820 ↗
36. 10.1016/j.bioactmat.2021.06.00310.1016/j.bioactmat.2021.06.003 ↗
37. 10.1002/adfm.20231478910.1002/adfm.202314789 ↗
38. 10.1021/acsnano.4c1291710.1021/acsnano.4c12917 ↗
39. 10.1021/jacsau.3c0009910.1021/jacsau.3c00099 ↗
40. 10.1002/adma.20240196010.1002/adma.202401960 ↗
41. 10.1038/s41566-024-01543-710.1038/s41566-024-01543-7 ↗
42. 10.1146/annurev-biochem-030222-12000010.1146/annurev-biochem-030222-120000 ↗
43. 10.1016/j.trac.2023.11705110.1016/j.trac.2023.117051 ↗
44. 10.1021/acs.accounts.6b0049110.1021/acs.accounts.6b00491 ↗
45. 10.1021/jacs.5c1021010.1021/jacs.5c10210 ↗
46. 10.1002/anie.20250664010.1002/anie.202506640 ↗
47. 10.1002/smll.20210083710.1002/smll.202100837 ↗
48. 10.1016/j.jss.2017.06.08310.1016/j.jss.2017.06.083 ↗
49. 10.1016/j.jtcme.2023.02.00810.1016/j.jtcme.2023.02.008 ↗
50. 10.2147/DDDT.S46609210.2147/DDDT.S466092 ↗
51. 10.1021/acscentsci.0c0076310.1021/acscentsci.0c00763 ↗
52. 10.1002/smll.20231169010.1002/smll.202311690 ↗